Your browser doesn't support javascript.
loading
Role of Thiol Reactivity for Targeting Mutant p53.
Zhang, Qiang; Bergman, Jan; Wiman, Klas G; Bykov, Vladimir J N.
Afiliação
  • Zhang Q; Karolinska Institutet, Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Stockholm SE-17176, Sweden.
  • Bergman J; Karolinska Institutet, Department of Bioscience and Nutrition, Huddinge SE-14157, Sweden.
  • Wiman KG; Karolinska Institutet, Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Stockholm SE-17176, Sweden. Electronic address: klas.wiman@ki.se.
  • Bykov VJN; Karolinska Institutet, Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Stockholm SE-17176, Sweden.
Cell Chem Biol ; 25(10): 1219-1230.e3, 2018 10 18.
Article em En | MEDLINE | ID: mdl-30057300
Reactivation of mutant p53 has emerged as a promising approach for cancer therapy. Recent studies have identified several mutant p53-reactivating compounds that target thiol groups in mutant p53. Here we have investigated the relationship between thiol reactivity, p53 thermostabilization, mutant p53 refolding, mutant p53-dependent growth suppression, and induction of cell death. Analysis of the National Cancer Institute database revealed that Michael acceptors show the highest selectivity for mutant p53-expressing cells among analyzed thiol-reactive compounds. Further experimental testing demonstrated that Michael acceptors, aldehydes, imines, and primary alcohols can promote thermodynamic stabilization of mutant p53. Moreover, mild thiol reactivity, often coupled with combined chemical functional groups, such as in imines, aldehydes, and primary alcohols, can stimulate mutant p53 refolding. However, strong electrophile activity was associated with cellular toxicity. Our findings may open possibilities for rational design of novel potent and selective mutant p53-reactivating compounds.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Sulfidrila / Proteína Supressora de Tumor p53 / Mutação Puntual / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Chem Biol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Sulfidrila / Proteína Supressora de Tumor p53 / Mutação Puntual / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Chem Biol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos